Mohamed Ehab Ali

564 total citations
11 papers, 436 citations indexed

About

Mohamed Ehab Ali is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Mohamed Ehab Ali has authored 11 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Biomaterials. Recurrent topics in Mohamed Ehab Ali's work include Advancements in Transdermal Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Mohamed Ehab Ali is often cited by papers focused on Advancements in Transdermal Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Mohamed Ehab Ali collaborates with scholars based in Germany, Egypt and France. Mohamed Ehab Ali's co-authors include Alf Lamprecht, Jason T. McConville, Salma N. Tammam, Maryam A. Shetab Boushehri, Sanjay Mathur, Hassan Mohamed El-Said Azzazy, Annette M. Schmidt, Mohammad Abdel‐Halim, Samar Mansour and Brice Moulari and has published in prestigious journals such as International Journal of Pharmaceutics, Colloids and Surfaces B Biointerfaces and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Mohamed Ehab Ali

11 papers receiving 435 citations

Peers

Mohamed Ehab Ali
Mohamed Ehab Ali
Citations per year, relative to Mohamed Ehab Ali Mohamed Ehab Ali (= 1×) peers Sonia Al‐Qadi

Countries citing papers authored by Mohamed Ehab Ali

Since Specialization
Citations

This map shows the geographic impact of Mohamed Ehab Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Ehab Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Ehab Ali more than expected).

Fields of papers citing papers by Mohamed Ehab Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Ehab Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Ehab Ali. The network helps show where Mohamed Ehab Ali may publish in the future.

Co-authorship network of co-authors of Mohamed Ehab Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Ehab Ali. A scholar is included among the top collaborators of Mohamed Ehab Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Ehab Ali. Mohamed Ehab Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Moulari, Brice, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, et al.. (2022). Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. Pharmaceutics. 14(2). 352–352. 12 indexed citations
2.
Ali, Mohamed Ehab, et al.. (2022). Immune Modifying Effect of Drug Free Biodegradable Nanoparticles on Disease Course of Experimental Autoimmune Neuritis. Pharmaceutics. 14(11). 2410–2410. 5 indexed citations
3.
Tammam, Salma N., Mohammad Abdel‐Halim, Mohamed Ehab Ali, et al.. (2020). Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting. European Journal of Pharmaceutics and Biopharmaceutics. 148. 54–66. 24 indexed citations
4.
Ali, Mohamed Ehab, et al.. (2019). Nanoparticle formulations as recrystallization inhibitors in transdermal patches. International Journal of Pharmaceutics. 575. 118886–118886. 26 indexed citations
5.
Ali, Mohamed Ehab, et al.. (2017). Artificial neural network based particle size prediction of polymeric nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 119. 333–342. 79 indexed citations
6.
Azzazy, Hassan Mohamed El-Said, Salma N. Tammam, Alf Lamprecht, et al.. (2016). Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue. Colloids and Surfaces B Biointerfaces. 146. 19–30. 31 indexed citations
7.
Ali, Mohamed Ehab & Alf Lamprecht. (2016). Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles. International Journal of Pharmaceutics. 516(1-2). 170–177. 60 indexed citations
8.
Ali, Mohamed Ehab & Alf Lamprecht. (2014). Spray freeze drying for dry powder inhalation of nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 87(3). 510–517. 108 indexed citations
9.
Ali, Mohamed Ehab, Jason T. McConville, & Alf Lamprecht. (2014). Pulmonary delivery of anti-inflammatory agents. Expert Opinion on Drug Delivery. 12(6). 929–945. 32 indexed citations
10.
Ali, Mohamed Ehab & Alf Lamprecht. (2013). Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation. International Journal of Pharmaceutics. 456(1). 135–142. 42 indexed citations
11.
Ahmad, Sayeed, et al.. (2011). Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release.. PubMed. 66(12). 956–60. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026